How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
58
LH Quote, Financials, Valuation and Earnings
Last price:
$272.23
Seasonality move
:
6.5%
Day range:
$265.73 - $271.86
52-week range:
$209.38 - $293.72
Dividend yield:
1.07%
P/E ratio:
26.54x
P/S ratio:
1.65x
P/B ratio:
2.58x
Volume:
514.8K
Avg. volume:
748.9K
1-year change:
8.2%
Market cap:
$22.4B
Revenue:
$13B
EPS (TTM):
$10.18
Analysts' Opinion
-
Consensus RatingLabcorp Holdings, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $300.06, Labcorp Holdings, Inc. has an estimated upside of 11.01% from its current price of $270.29.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $260.00 representing 3.81% downside risk from its current price of $270.29.
Fair Value
-
According to the consensus of 17 analysts, Labcorp Holdings, Inc. has 11.01% upside to fair value with a price target of $300.06 per share.
LH vs. S&P 500
-
Over the past 5 trading days, Labcorp Holdings, Inc. has overperformed the S&P 500 by 1.11% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Labcorp Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Labcorp Holdings, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Labcorp Holdings, Inc. reported revenues of $3.6B.
Earnings Growth
-
Labcorp Holdings, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Labcorp Holdings, Inc. reported earnings per share of $3.12.
Enterprise value:
28.4B
EV / Invested capital:
--
Price / LTM sales:
1.65x
EV / EBIT:
20.77x
EV / Revenue:
2.06x
PEG ratio (5yr expected):
0.27x
EV / Free cash flow:
20.54x
Price / Operating cash flow:
16.45x
Enterprise value / EBITDA:
13.88x
Gross Profit (TTM):
$3.6B
Return On Assets:
4.71%
Net Income Margin (TTM):
6.22%
Return On Equity:
10.25%
Return On Invested Capital:
5.61%
Operating Margin:
11.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $12.8B | $12.7B | $13.8B | $3.3B | $3.6B | |
| Gross Profit | $3.3B | $3.3B | $3.6B | $840.7M | $955.6M | |
| Operating Income | $1.3B | $1.1B | $1.4B | $272.1M | $403.2M | |
| EBITDA | $1.9B | $1.8B | $2B | $433.6M | $574.2M | |
| Diluted EPS | $7.48 | $5.16 | $10.18 | $2.01 | $3.12 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6B | $4.4B | $4B | $4.9B | $4.1B | |
| Total Assets | $20.9B | $19.8B | $16.9B | $18.6B | $18.3B | |
| Current Liabilities | $2.9B | $2.5B | $2.9B | $3.4B | $2.6B | |
| Total Liabilities | $10.3B | $9.7B | $9B | $10.4B | $9.5B | |
| Total Equity | $10.5B | $10.1B | $7.9B | $8.2B | $8.7B | |
| Total Debt | $6.1B | $6.1B | $6.2B | $7.5B | $6.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $1.4B | $1.8B | $277.3M | $387.2M | |
| Cash From Investing | -$1.1B | -$1.5B | -$1B | -$579.1M | -$374M | |
| Cash From Financing | $14.6M | $880.1M | -$1.7B | $1.5B | -$59.5M | |
| Free Cash Flow | $1B | $843.2M | $1.4B | $161.5M | $280.5M | |
LH
Sector
Market Cap
$22.4B
$24M
Price % of 52-Week High
92.02%
50%
Dividend Yield
1.07%
0%
Shareholder Yield
1.56%
-1.68%
1-Year Price Total Return
8.2%
-21.15%
Beta (5-Year)
1.029
0.502
Dividend yield:
1.07%
Annualized payout:
$2.88
Payout ratio:
23.08%
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$269.35
200-day SMA
Buy
Level
$261.38
Bollinger Bands (100)
Buy
Level
256.09 - 277.91
Chaikin Money Flow
Buy
Level
1.2M
20-day SMA
Buy
Level
$263.76
Relative Strength Index (RSI14)
Buy
Level
59.29
ADX Line
Sell
Level
10.27
Williams %R
Sell
Level
-18.6971
50-day SMA
Buy
Level
$261.39
MACD (12, 26)
Buy
Level
50.87
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
947.5K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7538)
Buy
CA Score
(Annual)
Level (-0.0945)
Buy
Beneish M-Score
(Annual)
Level (-2.7453)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.8573)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Stock Forecast FAQ
In the current month, LH has received 12 Buy ratings 5 Hold ratings, and 0 Sell ratings. The LH average analyst price target in the past 3 months is $300.06.
-
Where Will Labcorp Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Labcorp Holdings, Inc. share price will rise to $300.06 per share over the next 12 months.
-
What Do Analysts Say About Labcorp Holdings, Inc.?
Analysts are divided on their view about Labcorp Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Labcorp Holdings, Inc. is a Sell and believe this share price will drop from its current level to $260.00.
-
What Is Labcorp Holdings, Inc.'s Price Target?
The price target for Labcorp Holdings, Inc. over the next 1-year time period is forecast to be $300.06 according to 17 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is LH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Labcorp Holdings, Inc. is a Buy. 12 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LH?
You can purchase shares of Labcorp Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Labcorp Holdings, Inc. shares.
-
What Is The Labcorp Holdings, Inc. Share Price Today?
Labcorp Holdings, Inc. was last trading at $272.23 per share. This represents the most recent stock quote for Labcorp Holdings, Inc.. Yesterday, Labcorp Holdings, Inc. closed at $270.29 per share.
-
How To Buy Labcorp Holdings, Inc. Stock Online?
In order to purchase Labcorp Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LH
Sector
P/E ratio
26.54x
23.60x
PEG ratio
0.27x
-0.01x
P/B ratio
2.58x
1.78x
Price / LTM sales
1.65x
1.53x
Growth Metrics
LH
Sector
Revenue growth
8.58%
3.96%
Earnings growth
55.52%
10.7%
Revenue (5-year growth)
2.4%
6.15%
Earnings forecast
$3.94
-$0.19
Profitability
LH
Sector
Profitability FY 2024
$3.4B
$2.9M
Return on invested capital
5.61%
-33.43%
Return on assets
4.71%
-29.68%
Return on equity
10.25%
-38.98%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Feb
17
Estimated Next Earnings Date
Jan
27
Balance Sheet
LH
Sector
Total cash
$598.1M
$24.9M
Short term investments
--
$23.9M
Total assets
$18.4B
$71.9M
Long term debt
$6.3B
$2.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 43x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 43x
Alerts
Sell
49
HYMC alert for Feb 3
Hycroft Mining Holding Corp. [HYMC] is up 19.68% over the past day.
Buy
67
FBRX alert for Feb 3
Forte Biosciences, Inc. [FBRX] is down 0.2% over the past day.
Buy
72
BNR alert for Feb 3
Burning Rock Biotech Ltd. [BNR] is down 15.43% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
